Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K.-V. Toyka

Showing results (1-10 of 290) with videos related to

Pageof 29
Sort By:
Revue Neurologique|November 5, 1999
Eighty three years of the Guillain-Barré syndrome: clinical and immunopathologic aspects, current and future treatmentsK V Toyka
Muscle & Nerve|March 1, 1987
Humoral factors in peripheral nerve diseaseK V Toyka, K Heininger
European Neurology|October 26, 1999
Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]P Rieckmann, K V Toyka
Versicherungsmedizin|September 19, 2000
[Early diagnosis of multiple sclerosis]P Flachenecker, K V Toyka
Der Nervenarzt|September 24, 2002
[Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002]P Rieckmann, K V Toyka,
Journal of Neuroimmunology|August 1, 1985
Strategies for the modulation of neuroimmunological disease at the level of autoreactive T-lymphocytesR Hohlfeld, K V Toyka
Deutsche Medizinische Wochenschrift (1946)|September 19, 1986
[Acetylcholine receptor antibodies in the diagnosis of myasthenia gravis. Study of 406 confirmed cases]K V Toyka, K Heininger
Annals of the New York Academy of Sciences|December 10, 1999
Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathiesJ Zielasek, K V Toyka
Brain Research|December 1, 1987
Leukotriene production by cultured astroglial cellsH P Hartung, K V Toyka
Current Opinion in Neurology|June 1, 1996
Chronic inflammatory polyneuritis and neuropathiesK V Toyka, H P Hartung
Pageof 29

Showing results (1-10 of 290) with videos related to

Sort By:
Pageof 29
Revue Neurologique|November 5, 1999
Eighty three years of the Guillain-Barré syndrome: clinical and immunopathologic aspects, current and future treatmentsK V Toyka
Muscle & Nerve|March 1, 1987
Humoral factors in peripheral nerve diseaseK V Toyka, K Heininger
European Neurology|October 26, 1999
Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]P Rieckmann, K V Toyka
Versicherungsmedizin|September 19, 2000
[Early diagnosis of multiple sclerosis]P Flachenecker, K V Toyka
Der Nervenarzt|September 24, 2002
[Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002]P Rieckmann, K V Toyka,
Journal of Neuroimmunology|August 1, 1985
Strategies for the modulation of neuroimmunological disease at the level of autoreactive T-lymphocytesR Hohlfeld, K V Toyka
Deutsche Medizinische Wochenschrift (1946)|September 19, 1986
[Acetylcholine receptor antibodies in the diagnosis of myasthenia gravis. Study of 406 confirmed cases]K V Toyka, K Heininger
Annals of the New York Academy of Sciences|December 10, 1999
Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathiesJ Zielasek, K V Toyka
Brain Research|December 1, 1987
Leukotriene production by cultured astroglial cellsH P Hartung, K V Toyka
Current Opinion in Neurology|June 1, 1996
Chronic inflammatory polyneuritis and neuropathiesK V Toyka, H P Hartung
Pageof 29